Fabino Enterprises
20.31
0.00(0.00%)
Market Cap₹4.30 Cr
PE Ratio-7.64
IndustryHealthcare
Company Performance:
1D0.00%
1M0.00%
6M+21.25%
1Y-35.52%
5Y-49.67%
View Company Insightsright
More news about Fabino Enterprises
11Apr 26
Fabino Enterprises Ltd. Submits Q4FY26 Compliance Certificate to BSE
Fabino Enterprises Ltd. submitted its Q4FY26 compliance certificate to BSE on April 11, 2026, confirming non-applicability of SEBI Regulation 74(5) as all company shares remain in dematerialized form. The certificate, issued by registrar Bigshare Services Private Limited, reported no rematerialization or dematerialization requests during the quarter ended March 31, 2026, indicating complete digitization of the shareholding structure.
 no imag found
10Apr 26
Sushma Shekhar Acquires 8.29% Stake in Fabino Enterprises Through Open Market Purchase
Sushma Shekhar acquired 174,000 shares (8.29%) of Fabino Enterprises Ltd. through open market purchase on April 9, 2026. The acquirer, who is not part of the promoter group, previously held no shares in the BSE-listed company. The acquisition has been disclosed under SEBI Regulation 29, with the company's equity capital remaining at INR 2,10,00,000 divided into 21,00,000 shares of INR 10 each.
 no imag found
26Dec 25
Fabino Enterprises Independent Director Mr. Kuldeep Solanki Resigns with Immediate Effect
Fabino Enterprises Limited announced the immediate resignation of Non-Executive Independent Director Mr. Kuldeep Solanki (DIN: 07109951) effective December 26, 2025, citing pre-occupation and personal commitments. The company has informed BSE Limited under Regulation 30 of SEBI Listing Regulations and confirmed that succession planning will be addressed in the upcoming Board meeting.
 no imag found
26Dec 25
Fabino Enterprises Appoints Deepali Singla as Independent Director
Fabino Enterprises Limited has appointed Mrs. Deepali Singla (DIN: 11442242) as Additional Non-Executive Independent Director effective December 26, 2025, following a board meeting. She brings over six years of professional experience as an Associate at United Lex, specializing in document review, legal research, and regulatory compliance with exposure to Supreme Court and Delhi High Court proceedings.
 no imag found
Fabino Enterprises
20.31
0.0
(0.0%)
1 Year Returns:-35.52%
Industry Peers
Sun Pharmaceutical
1,868.00
(+0.27%)
Divis Laboratories
6,747.00
(-0.60%)
Torrent Pharmaceuticals
4,514.10
(+1.28%)
Cipla
1,433.10
(+1.23%)
Zydus Life Science
1,112.20
(+2.46%)
Dr Reddys Laboratories
1,301.30
(+0.82%)
Lupin
2,357.80
(+0.76%)
Mankind Pharma
2,528.60
(-0.38%)
Aurobindo Pharma
1,534.20
(+2.84%)
Laurus Labs
1,481.00
(+3.14%)